Antimalarial agent 49
Antimalarial agent 49 is an orally active antimalarial compound. Antimalarial agent 49 inhibits growth of Pf3D7 and PfK1 strains (IC50: 0.84 μM and 0.4 μM respectively) . Antimalarial agent 49 has antimalarial activity and inhibits the development of P. berghei liver stages. Antimalarial agent 49 can be used in the study of Plasmodium infection[1].
Product Specifications
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(C1=CC2=C(C(C3=CC=C(F)C=C3)=N1)NC4=C2C=CC=C4)NCC5=CN(C6=CC=CC(C(F)(F)F)=C6)N=N5
Molecular Formula
C28H18F4N6O
Molecular Weight
530.48
References & Citations
[1]Kushawaha AK, et al. Design, synthesis and evaluation of novel carboline-triazole hybrids as promising antimalarial agents. Eur J Med Chem. 2025 Jun 5;290:117514.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
244625 50 µL
CFC1 (cripto, FRL-1, cryptic Family 1, CRYPTIC, FLJ77897, HTX2, MGC133213)
Sign In for Pricing
View Details 
MR207482L3V 200 µL
Tmem151a (NM_001001885) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details